US Broker Ratings

Alvotech (ALVO): A 378% Upside Potential in the Biosimilar Market

Alvotech (ALVO), a prominent player in the healthcare sector specializing in the development and manufacturing of biosimilar medicines, presents a compelling investment opportunity with a staggering 377.73% potential upside according..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Navigating Growth in the Generic Drug Market

Investors with an eye on the healthcare sector might find Amneal Pharmaceuticals, Inc. (AMRX) a compelling prospect, especially as the company makes significant strides in the competitive landscape of generic..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Potential in the Dental Market

Envista Holdings Corporation (NYSE: NVST) is a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Brea, California, Envista has carved a niche..

QuidelOrtho Corporation (QDEL): Analyzing Its 47% Potential Upside in the Medical Devices Sector

QuidelOrtho Corporation (NASDAQ: QDEL) is a prominent player in the healthcare sector, specifically within the medical devices industry. Headquartered in San Diego, California, the company delivers diagnostic testing solutions that..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Exploring a 27% Upside Potential in the Biotech Sector

PTC Therapeutics, Inc. (NASDAQ: PTCT) stands out in the biotechnology industry with a market cap of $5.58 billion and a focus on developing treatments for rare disorders. As the company..

ImmunityBio, Inc. (IBRX)

⚠️ No article content returned.

..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: A 190% Potential Upside Awaits Investors

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a pioneering biopharmaceutical company, stands at the forefront of developing therapies for rare and ultra-rare genetic diseases. Based in Novato, California, the company is renowned..

Surgery Partners, Inc. (SGRY) Stock Analysis: Is the 64.65% Upside Potential Within Reach?

Surgery Partners, Inc. (NASDAQ: SGRY) stands as a notable player within the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of $2 billion, this Brentwood,..

ICU Medical, Inc. (ICUI) Investor Outlook: 24.8% Potential Upside Amidst Healthcare Innovation

ICU Medical, Inc. (NASDAQ: ICUI), a key player in the medical instruments and supplies industry, offers a compelling prospect for investors seeking exposure to the healthcare sector. Based in San..

CRISPR Therapeutics AG (CRSP)

⚠️ No article content returned.

..

BrightSpring Health Services, Inc. (BTSG) Stock Analysis: A 14.43% Potential Upside Beckons Investors

BrightSpring Health Services, Inc. (BTSG), a prominent player in the Healthcare sector, specifically within Health Information Services, is captivating investor attention with its significant potential upside of 14.43%. Headquartered in..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Evaluating a 38.65% Potential Upside in the Dynamic Medical Devices Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP) stands out in the medical devices sector with its innovative approach to treating obstructive sleep apnea (OSA). Headquartered in Golden Valley, Minnesota, Inspire Medical..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating Market Volatility in the Medical Device Sector

Integer Holdings Corporation (NYSE: ITGR) operates at the heart of the healthcare sector, focusing on the design and manufacturing of medical devices. With a market capitalization of $3.01 billion, this..

TransMedics Group, Inc. (TMDX) Stock Analysis: Unlocking a 11% Upside in the Medical Device Sector

TransMedics Group, Inc. (NASDAQ: TMDX) is a compelling player in the healthcare sector, specifically within the medical devices industry. With its innovative approach to organ transplant therapy, the company is..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating the Challenges of a $15.44 Billion Market Cap in the TCM Sector

Regencell Bioscience Holdings Limited (NASDAQ: RGC) stands at a fascinating intersection of healthcare innovation and traditional Chinese medicine (TCM), focusing on the development and commercialization of treatments for neurocognitive disorders..

Waystar Holding Corp. (WAY) Stock Analysis: Exploring a Potential 108% Upside with Strong Buy Ratings

Investors are increasingly turning their attention to Waystar Holding Corp. (WAY), a key player in the Health Information Services industry, particularly after recent analyst ratings suggest a significant potential upside...

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Promising Play in Genetic Medicine with a 2.89% Upside Potential

Krystal Biotech, Inc. (NASDAQ: KRYS) has emerged as a compelling player in the healthcare sector, particularly within the biotechnology industry, as it continues to make strides in the development and..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: A 44% Upside Potential in the Biotech Space

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is a key player in the biotechnology sector, focusing on the development of treatments for rare neuroendocrine diseases. As a commercial-stage biopharmaceutical company, Rhythm has..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Assessing the 19.95% Potential Upside Amidst Biotech Innovations

Roivant Sciences Ltd. (NASDAQ: ROIV), a prominent name in the biotechnology sector, is making waves with its ambitious strides in medical technologies and drug development. Founded in 2014 and based..

Grifols, S.A. (GRFS) Stock Analysis: Unveiling a 19.10% Potential Upside in the Healthcare Sector

Investors looking for opportunities in the healthcare sector could find Grifols, S.A. (NASDAQ: GRFS) a compelling consideration. This Spanish pharmaceutical company, specializing in plasma-derived therapies and biological products, is positioned..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds